Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Finding budgeting mistakes is essential for financial success. Explore methods to uncover and correct these errors.
9,941 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Strong U.S. jobs data rekindled concerns about liquidity in crypto markets. The resilient jobs market keeps policy in...
A fresh analysis connects men’s decisions to leave work with what they see during childhood about wages and unemploym...
A promising AI-driven play could redefine long-term portfolios. Learn why this stock might be a once-in-a-decade inve...
Swell has halted its Swellchain on the Optimism Superchain, leaving users scrambling to recover assets as the latest ...
Binance withdraws its MiCA filing in Greece, signaling a broader EU strategy as July 1 approaches. European users fac...
Bitcoin hovered near the $60,000 mark but briefly slid toward $58,000 as ETF outflows intensified and inflation data ...
Insider sales spark questions about a stock's health. Here's a practical, data-backed guide to interpret a VP selling...
Global markets rose late Sunday as the U.S. and Iran signaled a pause in hostilities and agreed to talks, easing fear...
A big wave of Iranian crude has hit global markets after Washington opened waivers, potentially adding 130-150 millio...
A large insider sale often sparks questions about a company’s future. This article breaks down what the move means, h...
A Scattered Spider suspect extradited to the US shines a light on how cross-border cybercrime prosecutions unfold. Th...